Form 4: HCA Healthcare SVP and CIO Chad Wasserman Executes Stock Appreciation Rights and Sells Shares Under 10b5-1 Plan

Chad Wasserman, SVP and CIO of HCA Healthcare, exercised stock appreciation rights and sold shares of common stock under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On March 18, 2024, Chad Wasserman, SVP and CIO of HCA Healthcare, exercised stock appreciation rights, acquiring 2,100 shares of common stock at a price of $101.16.
• Simultaneously, Wasserman disposed of shares to cover tax obligations and sold additional shares on the open market.
• Specifically, 1,224 shares were disposed of at $327.17 per share to cover tax obligations, 344 shares were sold at $321.97 per share, and 876 shares were sold on March 20, 2024, at $330.25 per share.
• These transactions were executed under a Rule 10b5-1 trading plan adopted on November 16, 2023.
• Following these transactions, Wasserman directly owns 1,576.3102 shares of HCA Healthcare common stock and 4,190 stock appreciation rights.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The transactions are part of a pre-planned trading strategy and do not necessarily indicate a positive or negative outlook on the company's performance.

Positives

• The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, which can mitigate concerns about insider trading.

Future Outlook

NA

Industry Context

Executive stock transactions are common and closely monitored, especially in publicly traded companies like HCA Healthcare. Rule 10b5-1 plans are frequently used to allow insiders to sell shares without raising concerns about trading on non-public information.

Comparison to Industry Standards

• Executive compensation packages often include stock options and appreciation rights to align management's interests with those of shareholders.
• The use of Rule 10b5-1 trading plans is a standard practice among corporate executives to manage their stock holdings while avoiding potential insider trading accusations.
• Comparable companies such as Tenet Healthcare and Universal Health Services also see regular Form 4 filings related to executive stock transactions.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the small volume of shares involved.
• The transactions do not appear to have a significant impact on employees, customers, suppliers, or creditors.

Key Dates